Anna S. Pirogova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Anna S. Pirogova has a total of 90 co-authors. Here are the top co-authors by number of shared publications:
- Natalia Pavlovna Teplyuk
Sechenov First Moscow State Medical University (Sechenov University)
7 shared publications - Alexey Viktorovich Samtsov
Military Medical Academy named after S.M. Kirov
2 shared publications - Darya D. Shlyk
I.M. Sechenov First Moscow State Medical University (Sechenov University)
2 shared publications - Elena Roaldovna Araviiskaia
Pavlov First Saint Petersburg State Medical University
2 shared publications - Evgeniy Vladislavovich Sokolovskiy
Academician I.P. Pavlov First St. Petersburg State Medical University
2 shared publications - L.P. Kotrekhova
North-Western State Medical University Named After I.I. Mechnikov
2 shared publications
Latest Publications
- Top Cited PapersOpen Access
- 24 January 2026
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
Delphi consensus: First‐line use of biologics and small molecules in hidradenitis suppurativa
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease associated with significant diagnostic delays and impact on quality of life. Current guidelines prioritize antibiotics as first‐line therapy, but experts increasingly recognize the need for earlier targeted therapy intervention to prevent irreversible scarring and tunnel formation. To establish consensus on clinical scenarios during the 14th European Hidradenitis Suppurativa Foundation Conference in February 2025, 54 HS experts participated in a Delphi consensus, using a Likert scale (−5 to +5) to vote on 16 statements concerning first‐line therapy criteria with biologics and/or small molecules for eligible patients. Seventy‐eight HS experts were invited, and 54 participated via hybrid onsite and electronic voting. Experts rated 16 pre‐defined statements regarding first‐line use of biologics and/or small molecules for HS using a Likert scale (−5 to +5). Agreement metrics were stratified as majority agreement (≥70%, median 3.0–3.5), consensus (≥75%, median 3.5–4.5), and strong consensus (≥90%, median ≥4.5). Statements were subsequently ranked for clinical relevance. Strong consensus was reached for patients contraindicated for antibiotics, rapid disease progressors and those with severe disease. Consensus also supported upgrading patients with moderate disease (IHS4 ≥ 4), frequent flares (≥3 in 12 weeks), multiple affected areas and specific phenotypes including anogenital involvement. Strong consensus emerged for syndromic HS and for patients with inflammatory comorbidities such as inflammatory bowel disease and arthritis. Paediatric patients with a positive family history and moderate disease were also considered candidates for first‐line biologics or small molecules. This consensus provides evidence‐based criteria for upgrading HS patients to first‐line biologic therapy, reflecting expert practices across Europe aimed at preventing irreversible disease progression. The results support a ‘hit hard and early’ approach to minimize scarring and tunnel formation, although prospective studies are still needed to validate these expert‐driven recommendations.
- 24 January 2026
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
Top Cited PapersOpen AccessDelphi consensus: First‐line use of biologics and small molecules in hidradenitis suppurativa
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease associated with significant diagnostic delays and impact on quality of life. Current guidelines prioritize antibiotics as first‐line therapy, but experts increasingly recognize the need for earlier targeted therapy intervention to prevent irreversible scarring and tunnel formation. To establish consensus on clinical scenarios during the 14th European Hidradenitis Suppurativa Foundation Conference in February 2025, 54 HS experts participated in a Delphi consensus, using a Likert scale (−5 to +5) to vote on 16 statements concerning first‐line therapy criteria with biologics and/or small molecules for eligible patients. Seventy‐eight HS experts were invited, and 54 participated via hybrid onsite and electronic voting. Experts rated 16 pre‐defined statements regarding first‐line use of biologics and/or small molecules for HS using a Likert scale (−5 to +5). Agreement metrics were stratified as majority agreement (≥70%, median 3.0–3.5), consensus (≥75%, median 3.5–4.5), and strong consensus (≥90%, median ≥4.5). Statements were subsequently ranked for clinical relevance. Strong consensus was reached for patients contraindicated for antibiotics, rapid disease progressors and those with severe disease. Consensus also supported upgrading patients with moderate disease (IHS4 ≥ 4), frequent flares (≥3 in 12 weeks), multiple affected areas and specific phenotypes including anogenital involvement. Strong consensus emerged for syndromic HS and for patients with inflammatory comorbidities such as inflammatory bowel disease and arthritis. Paediatric patients with a positive family history and moderate disease were also considered candidates for first‐line biologics or small molecules. This consensus provides evidence‐based criteria for upgrading HS patients to first‐line biologic therapy, reflecting expert practices across Europe aimed at preventing irreversible disease progression. The results support a ‘hit hard and early’ approach to minimize scarring and tunnel formation, although prospective studies are still needed to validate these expert‐driven recommendations.
- Open Access
- 23 October 2024
- Published by RPO Surgical Society - Wound and Wound Infections in Wounds and wound infections. The prof. B.M. Kostyuchenok journal
- Vol. 11 (2) , 36-43
A one-stage radical surgical treatment of hidradenitis suppurativa of stage III by the Hurley classification of axillary location with wound plastic surgery using a posterior shoulder flap (a clinical case)
Hidradenitis suppurativa (acne inversa) is a chronic inflammatory skin disease that affects terminal hair follicles in the area of apocrine sweat glands. The disease is manifested by the formation of recurrent inflammatory nodes with purulent discharge, prone to the formation of fistulas and scars. The axillary region is one of the common affected areas.The article presented a clinical case of radical surgical management of hidradenitis suppurativa of stage III by the Hurley classification. The described surgical treatment included extensive resection of pathologically changed soft tissues of the axillary region with simultaneous wound repair using a displaced fascio-cutaneous flap taken from the posterior surface of the shoulder.
- 23 October 2024
- Published by RPO Surgical Society - Wound and Wound Infections in Wounds and wound infections. The prof. B.M. Kostyuchenok journal
- Vol. 11 (2) , 36-43
Open AccessA one-stage radical surgical treatment of hidradenitis suppurativa of stage III by the Hurley classification of axillary location with wound plastic surgery using a posterior shoulder flap (a clinical case)
Hidradenitis suppurativa (acne inversa) is a chronic inflammatory skin disease that affects terminal hair follicles in the area of apocrine sweat glands. The disease is manifested by the formation of recurrent inflammatory nodes with purulent discharge, prone to the formation of fistulas and scars. The axillary region is one of the common affected areas.The article presented a clinical case of radical surgical management of hidradenitis suppurativa of stage III by the Hurley classification. The described surgical treatment included extensive resection of pathologically changed soft tissues of the axillary region with simultaneous wound repair using a displaced fascio-cutaneous flap taken from the posterior surface of the shoulder.
- Open Access
- 10 July 2024
- Published by Rossijskoe Obschestvo Dermatovenerologov i Kosmetologov in Vestnik dermatologii i venerologii
- Vol. 100 (3) , 7-16
Hidradenitis suppurativa: review of international clinical guidelines for the diagnosis and treatment of the disease
Background. Hidradenitis suppurativa hidradenitis is a chronic recurrent inflammatory skin disease that develops after puberty and is characterized by the appearance of recurrent painful nodes, abscesses, the formation of fistula passages and scars on skin areas rich in apocrine sweat glands. Treatment of purulent hidradenitis is aimed at suppressing inflammation, relieving pain, preventing the formation of fistulas and scars. The objectives of this review. Summarize the information in the published international clinical guidelines for the diagnosis and treatment of purulent hidradenitis, their comprehensive assessment and comparison with each other. Methods. In the period from December 2022 to February 2023, scientific articles were searched in the PubMed database of the National Center for Biotechnological Information. Inclusion criteria: scientific articles in English, without date restrictions; interdisciplinary publications of specialists in which dermatovenereologists participated. Results. The analysis of the existing relevant international clinical recommendations for the diagnosis and treatment of purulent hidradenitis indicates the absence of specific treatment schemes and algorithms, criteria for evaluating the effectiveness of therapy. In the treatment of purulent hidradenitis, the use of external keratolytics, antiseptics and antibiotics is recommended. Among systemic drugs, antibiotics, retinoids, immunosuppressive agents, hormonal drugs are used. The highest therapeutic efficacy in patients with purulent hidradenitis was shown by genetically engineered drugs that inhibit TNF-α and IL-17A. Conclusions. Patients with purulent hidradenitis require various treatment approaches, including a variety of surgical interventions, depending on the stage, severity, prescription of the disease and the general condition of the patient. The basic principle is the individual selection of the treatment method for a particular patient. In this regard, there is a need to develop domestic clinical guidelines for the management of patients with purulent hidradenitis.
- 10 July 2024
- Published by Rossijskoe Obschestvo Dermatovenerologov i Kosmetologov in Vestnik dermatologii i venerologii
- Vol. 100 (3) , 7-16
Open AccessHidradenitis suppurativa: review of international clinical guidelines for the diagnosis and treatment of the disease
Background. Hidradenitis suppurativa hidradenitis is a chronic recurrent inflammatory skin disease that develops after puberty and is characterized by the appearance of recurrent painful nodes, abscesses, the formation of fistula passages and scars on skin areas rich in apocrine sweat glands. Treatment of purulent hidradenitis is aimed at suppressing inflammation, relieving pain, preventing the formation of fistulas and scars. The objectives of this review. Summarize the information in the published international clinical guidelines for the diagnosis and treatment of purulent hidradenitis, their comprehensive assessment and comparison with each other. Methods. In the period from December 2022 to February 2023, scientific articles were searched in the PubMed database of the National Center for Biotechnological Information. Inclusion criteria: scientific articles in English, without date restrictions; interdisciplinary publications of specialists in which dermatovenereologists participated. Results. The analysis of the existing relevant international clinical recommendations for the diagnosis and treatment of purulent hidradenitis indicates the absence of specific treatment schemes and algorithms, criteria for evaluating the effectiveness of therapy. In the treatment of purulent hidradenitis, the use of external keratolytics, antiseptics and antibiotics is recommended. Among systemic drugs, antibiotics, retinoids, immunosuppressive agents, hormonal drugs are used. The highest therapeutic efficacy in patients with purulent hidradenitis was shown by genetically engineered drugs that inhibit TNF-α and IL-17A. Conclusions. Patients with purulent hidradenitis require various treatment approaches, including a variety of surgical interventions, depending on the stage, severity, prescription of the disease and the general condition of the patient. The basic principle is the individual selection of the treatment method for a particular patient. In this regard, there is a need to develop domestic clinical guidelines for the management of patients with purulent hidradenitis.
- Open Access
- 20 May 2024
- Published by Rossijskoe Obschestvo Dermatovenerologov i Kosmetologov in Vestnik dermatologii i venerologii
- Vol. 100 (2) , 18-30
Hidradenitis suppurativa: definition, epidemiology, etiology, diagnosis (part 1)
Hidradenitis suppurativa (HS) is a chronic recurrent skin disease characterized by development of autoimmune inflammation in the infundibulum of the hair follicle and apocrine sweat glands located in the axillary, inguinal, anogenital regions, submammary folds, near the areola of mammary glands and the umbilical region. HS is difficult to treat and has an extremely negative impact on the quality of life. HS is separated into a distinct clinical entity fundamentally different in etiopathogenesis from acute bacterial hidradenitis. The exact prevalence of HS is unknown, it varies greatly in different studies ranging from 0.03 to 4% in general population. The detection of IL-1β, IL-23, and IL-17 in the lesions indicates the key role of autoimmune inflammation involving Th17-lymphocytes in the pathogenesis of HS. Risk factors include smoking, obesity, mechanical friction, genetic predisposition. The diagnosis of HS relies on three obligatory criteria: characteristic distribution, typical morphology of the lesions and relapsing, chronic disease course. There is no “gold standard” in assessing the severity of the disease, since all available scoring systems have many limitations, therefore many questions regarding this disease remain unsolved at present — from terminology and clear and most objective assessment criteria for the severity of the process to the development of native clinical guidelines.
- 20 May 2024
- Published by Rossijskoe Obschestvo Dermatovenerologov i Kosmetologov in Vestnik dermatologii i venerologii
- Vol. 100 (2) , 18-30
Open AccessHidradenitis suppurativa: definition, epidemiology, etiology, diagnosis (part 1)
Hidradenitis suppurativa (HS) is a chronic recurrent skin disease characterized by development of autoimmune inflammation in the infundibulum of the hair follicle and apocrine sweat glands located in the axillary, inguinal, anogenital regions, submammary folds, near the areola of mammary glands and the umbilical region. HS is difficult to treat and has an extremely negative impact on the quality of life. HS is separated into a distinct clinical entity fundamentally different in etiopathogenesis from acute bacterial hidradenitis. The exact prevalence of HS is unknown, it varies greatly in different studies ranging from 0.03 to 4% in general population. The detection of IL-1β, IL-23, and IL-17 in the lesions indicates the key role of autoimmune inflammation involving Th17-lymphocytes in the pathogenesis of HS. Risk factors include smoking, obesity, mechanical friction, genetic predisposition. The diagnosis of HS relies on three obligatory criteria: characteristic distribution, typical morphology of the lesions and relapsing, chronic disease course. There is no “gold standard” in assessing the severity of the disease, since all available scoring systems have many limitations, therefore many questions regarding this disease remain unsolved at present — from terminology and clear and most objective assessment criteria for the severity of the process to the development of native clinical guidelines.
- Open Access
- 1 December 2023
- Published by Russian Gastroenterolgocial Society in Russian Journal of Gastroenterology, Hepatology, Coloproctology
- Vol. 33 (6) , 53-64
Follicular Occlusion Syndrome — a Possible Option of Follicular-Retension Origin of Pilonidal Sinus
Синдром фолликулярной окклюзии — возможный вариант фолликулярно-ретенционного происхождения эпителиального копчикового хода
- 1 December 2023
- Published by Russian Gastroenterolgocial Society in Russian Journal of Gastroenterology, Hepatology, Coloproctology
- Vol. 33 (6) , 53-64
Open AccessFollicular Occlusion Syndrome — a Possible Option of Follicular-Retension Origin of Pilonidal Sinus
Синдром фолликулярной окклюзии — возможный вариант фолликулярно-ретенционного происхождения эпителиального копчикового хода
- Open Access
- 21 May 2023
- Published by ECO-Vector LLC in Russian Journal of Skin and Venereal Diseases
- Vol. 26 (2) , 157-170
The experience of follicular occlusion syndrome treatment with tumor necrosis factor inhibitors
Follicular occlusion syndrome consists of several conditions that share similar pathophysiology involving infundibular follicular occlusion and secondary inflammatory cascade. This syndrome includes hidradenitis suppurativa, dissecting cellulitis of the scalp, acne conglobata and pilonidal sinus. They can develop independently or as a component of a syndrome in different combinations. We are the first to present a clinical case of follicular occlusion tetrad and intermediate therapy outcome with tumor necrosis factor inhibitors. We also provide a full and updated review of the literature on the etiology and pathogenesis, diagnosis and treatment of similar syndromic conditions. Currently, there is no reliable algorithm of treatment for patients with follicular occlusion syndrome, which underlines the importance of further studies. The presented clinical case confirms the need for timely administration of genetically-engineered biological drugs to patients with diseases of the follicular occlusion group (before sinus tract formation).
- 21 May 2023
- Published by ECO-Vector LLC in Russian Journal of Skin and Venereal Diseases
- Vol. 26 (2) , 157-170
Open AccessThe experience of follicular occlusion syndrome treatment with tumor necrosis factor inhibitors
Follicular occlusion syndrome consists of several conditions that share similar pathophysiology involving infundibular follicular occlusion and secondary inflammatory cascade. This syndrome includes hidradenitis suppurativa, dissecting cellulitis of the scalp, acne conglobata and pilonidal sinus. They can develop independently or as a component of a syndrome in different combinations. We are the first to present a clinical case of follicular occlusion tetrad and intermediate therapy outcome with tumor necrosis factor inhibitors. We also provide a full and updated review of the literature on the etiology and pathogenesis, diagnosis and treatment of similar syndromic conditions. Currently, there is no reliable algorithm of treatment for patients with follicular occlusion syndrome, which underlines the importance of further studies. The presented clinical case confirms the need for timely administration of genetically-engineered biological drugs to patients with diseases of the follicular occlusion group (before sinus tract formation).
- 7 April 2023
- Published by ECO-Vector LLC in Russian Journal of Skin and Venereal Diseases
- Vol. 26 (1) , 95-100
Photogallery. Follicular occlusion syndrome
Hidradenitis suppurativa, dissecting cellulitis of the scalp, acne conglobata and pilonidal sinus ― are four diseases united by similar clinical findings and common mechanisms of pathogenesis. These conditions often coexist. The primer pathogenetic event is stratum corneum thickening and keratin plugging of the hair follicle ductal isthmus. The discovery of this mechanism led to association of all the diseases with the term "follicular occlusion syndrome". If three nosologies are detected follicular occlusion triad is diagnosed, if four are present ― follicular occlusion tetrad. We present a photogallery on this problem.
- 7 April 2023
- Published by ECO-Vector LLC in Russian Journal of Skin and Venereal Diseases
- Vol. 26 (1) , 95-100
Photogallery. Follicular occlusion syndrome
Hidradenitis suppurativa, dissecting cellulitis of the scalp, acne conglobata and pilonidal sinus ― are four diseases united by similar clinical findings and common mechanisms of pathogenesis. These conditions often coexist. The primer pathogenetic event is stratum corneum thickening and keratin plugging of the hair follicle ductal isthmus. The discovery of this mechanism led to association of all the diseases with the term "follicular occlusion syndrome". If three nosologies are detected follicular occlusion triad is diagnosed, if four are present ― follicular occlusion tetrad. We present a photogallery on this problem.
- 3 January 2023
- Published by ECO-Vector LLC in Russian Medicine
- Vol. 28 (6) , 465-473
Follicular occlusion syndrome in the practice of a coloproctologist
BACKGROUND: Pilonidal disease is the 4th most common disease among inpatient coloproctological patients and surgery remains the gold standard of its treatment. However, patients with pilonidal disease often have combined conditions with other follicular occlusion diseases which are most often encountered by dermatologists in their practice. In most cases it is difficult to treat follicular occlusion syndrome with pilonidal disease within one specialty. We demonstrate the complexity of follicular occlusion diseases diagnostics in combination with pilonidal disease, systemize the diagnostic protocol for patient management and present the treatment strategy for coloproctologists. CLINICAL CASE DESCRIPTION: There was one case of patient with pilonidal disease combined with other conditions of follicular occlusion syndrome noted in the clinic of coloproctology and minimally invasive surgery. Surgery was the first step. There were no complications in the early postoperative period. After hospital discharge, the patient was consulted by a dermatologist, and local and systemic conservative therapy was prescribed for concomitant diseases, which resulted in a significant improvement. There have been no recent reports of recurrence. CONCLUSION: The treatment of follicular occlusion syndrome with pilonidal disease requires a multidisciplinary approach. At the same time the optimal treatment for pilonidal disease is radical excision of all altered tissues. In cases of such diseases as hidradenitis suppurativa, acne conglobata, dissecting cellulitis of the scalp treatment should be comprehensive and begin with a dermatologist consultation.
- 3 January 2023
- Published by ECO-Vector LLC in Russian Medicine
- Vol. 28 (6) , 465-473
Follicular occlusion syndrome in the practice of a coloproctologist
BACKGROUND: Pilonidal disease is the 4th most common disease among inpatient coloproctological patients and surgery remains the gold standard of its treatment. However, patients with pilonidal disease often have combined conditions with other follicular occlusion diseases which are most often encountered by dermatologists in their practice. In most cases it is difficult to treat follicular occlusion syndrome with pilonidal disease within one specialty. We demonstrate the complexity of follicular occlusion diseases diagnostics in combination with pilonidal disease, systemize the diagnostic protocol for patient management and present the treatment strategy for coloproctologists. CLINICAL CASE DESCRIPTION: There was one case of patient with pilonidal disease combined with other conditions of follicular occlusion syndrome noted in the clinic of coloproctology and minimally invasive surgery. Surgery was the first step. There were no complications in the early postoperative period. After hospital discharge, the patient was consulted by a dermatologist, and local and systemic conservative therapy was prescribed for concomitant diseases, which resulted in a significant improvement. There have been no recent reports of recurrence. CONCLUSION: The treatment of follicular occlusion syndrome with pilonidal disease requires a multidisciplinary approach. At the same time the optimal treatment for pilonidal disease is radical excision of all altered tissues. In cases of such diseases as hidradenitis suppurativa, acne conglobata, dissecting cellulitis of the scalp treatment should be comprehensive and begin with a dermatologist consultation.
- Open Access
- 29 November 2022
- Published by ECO-Vector LLC in Russian Journal of Skin and Venereal Diseases
- Vol. 25 (4) , 337-340
Photogallery. Hidradenitis suppurativa (acne inversa)
Hidradenitis suppurativa (acne inversa) is a chronic, inflammatory, primary follicular disease triggered by follicular occlusion with subsequent inflammation and destruction of the skin appendage, affecting hair follicles located in apocrine gland-bearing body areas. Clinical presentation of hidradenitis suppurativa is extremely variable showing a wide spectrum of cutaneous lesions in different stages of evolution, different pattern of distribution and grades of severity. Traditionally for severity staging the Hurley clinical grading system has been used where stage I stands for mild disease while stage II and III for moderate and severe stages respectively. 2015 classification of Van Der Zee and Jemec proposed 6 phenotypes of hidradenitis suppurativa: regular type, frictional furuncle type, scarring folliculitis type, conglobata type, syndromic type, ectopic type. We present a photogallery on this problem.
- 29 November 2022
- Published by ECO-Vector LLC in Russian Journal of Skin and Venereal Diseases
- Vol. 25 (4) , 337-340
Open AccessPhotogallery. Hidradenitis suppurativa (acne inversa)
Hidradenitis suppurativa (acne inversa) is a chronic, inflammatory, primary follicular disease triggered by follicular occlusion with subsequent inflammation and destruction of the skin appendage, affecting hair follicles located in apocrine gland-bearing body areas. Clinical presentation of hidradenitis suppurativa is extremely variable showing a wide spectrum of cutaneous lesions in different stages of evolution, different pattern of distribution and grades of severity. Traditionally for severity staging the Hurley clinical grading system has been used where stage I stands for mild disease while stage II and III for moderate and severe stages respectively. 2015 classification of Van Der Zee and Jemec proposed 6 phenotypes of hidradenitis suppurativa: regular type, frictional furuncle type, scarring folliculitis type, conglobata type, syndromic type, ectopic type. We present a photogallery on this problem.
- 16 July 2021
- Published by ECO-Vector LLC in Russian Journal of Skin and Venereal Diseases
- Vol. 24 (1) , 71-77
Clinical case of acne inversa
Acne inversa is a rare skin disease characterized by recurrent nodules and abscesses that rupture with suppurative discharge and lead to sinus tracts and scarring. The disease is chronic and debilitating. In typical cases, it is diagnosed at late stages, when more aggressive therapeutic treatment is obligatory. There is not generally any accepted therapeutic algorithms, therefore, it is a difficult-to-manage disease, which determines the necessity for further study. We present a clinical case of acne inversa with non-classical phenotypic features and the results of its treatment with systemic retinoids, and metformin. We also provide a review of the literature on the etiology, pathogenesis, and diagnosis of acne inversa. Currently, there is no reliable algorithms of diagnostics and effective treatment for patients with acne inversa, which underlines the importance of further study of this disease.
- 16 July 2021
- Published by ECO-Vector LLC in Russian Journal of Skin and Venereal Diseases
- Vol. 24 (1) , 71-77
Clinical case of acne inversa
Acne inversa is a rare skin disease characterized by recurrent nodules and abscesses that rupture with suppurative discharge and lead to sinus tracts and scarring. The disease is chronic and debilitating. In typical cases, it is diagnosed at late stages, when more aggressive therapeutic treatment is obligatory. There is not generally any accepted therapeutic algorithms, therefore, it is a difficult-to-manage disease, which determines the necessity for further study. We present a clinical case of acne inversa with non-classical phenotypic features and the results of its treatment with systemic retinoids, and metformin. We also provide a review of the literature on the etiology, pathogenesis, and diagnosis of acne inversa. Currently, there is no reliable algorithms of diagnostics and effective treatment for patients with acne inversa, which underlines the importance of further study of this disease.